Web Search Site Search Webcast: Interviews - 1st Intl Workshop on HIV & Aging, Baltimore, MD Oct, 2010 (click here to View)   Slide Orals, Abstracts Online from the 1st International Workshop on Aging & HIV click here for details   Ryan White Care Act Hepatitis C & B Language (click here for details)   Current HIV Articles and News Updates     HIV     Vitamin D and UVB Radiation: How Much Is Necessary? "Exposure to a UVB dose of 1 SED every second week to ~88% body area is sufficient for maintaining summer 25(OH)D levels during the winter." - pdf attached - (02/03/12)   More HIV Articles...         News Updates     Pfizer in talks with buyer for Sandwich, FDA approves Inlyta - (02/03/12)   Once Weekly Diabetes Drug Wins FDA Approval on Third Try - (02/03/12)   FDA approves Roche's skin cancer drug Erivedge - (02/03/12)   Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier¨ Treatment Protocol - (02/03/12)   US Medicaid Rx drug move will save $17.7B, says govt - (02/03/12)   EU Commission tells Italy: "comply with rules on generics" - (02/03/12)   Spain cut Rx spending 8.8% in 2011, but owes drugmakers 6.3B euros - (02/03/12)   More News Updates Articles...     Current Hepatitis C and B Articles     Hepatitis C     Early HCV Treatment, [Cost] Effectiveness of Fibrosis Assessment Before Therapy - (02/03/12)   Nurse HCV Care/Treatment Adherence Support/Education Systems Improve SVR - (02/03/12)   A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse - (02/03/12)   Victrelis-New Hep C treatment available in Australia - (02/03/12)   Medivir/Tibotec HCV Drug Development - (02/03/12)   Gilead Sciences' CEO Discusses Q4 2011 Results - Earnings Call Transcript (PSI-7977 Gt1 HCV Discussion: Norbert W. Bischofberger) - (02/03/12)   HCV/Heroin Epidemic in Youth Nationwide: Cortland (NYS) sees spike in Hepatitis C in young drug users/new report - (02/03/12)   Studies Illustrate Role of HCV Infection As Risk Factor for Liver Cancer Researchers Stress Importance of Early Detection of HCV: 'HCV now is leading cause of liver cancer in US, liver cancer rates were 2-3 times higher in Mayo Clinic study than currently reported national rates, immigrants are coming into US with higher than expected rates of HCV, screening/treatment guidelines should be considered' - (02/03/12)   Quadruple Therapy With BMS-790052, BMS-650032 and Peg-IFN/RBV for 24 Weeks Results in 100% SVR12 in HCV Genotype 1 Null Responders: original slide presentation at EASL April 2011 Proof of Concept that SVR is Achievable Without Peg/RBV - 4/11 null responder patients achieved SVR w/o Peg/Rbv, with only BMS-790052 (NS5A inhibitor) + BMS-650032 (protease inh) - (02/03/12)   Triple Therapy Using Telaprevir In The Treatment of Hepatitis C Recurrence After Liver Transplantation: An Early Single Center Experience. - (02/03/12)   More Hep C Articles...         Hepatitis B     Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome - (02/03/12)   More Hep B Articles...   Check Out Our Special NATAP Features     Link to conference listings   Virology Education HIV and Women Workshop January 10th 11th 2011 Washington DC www.virology-education.com   CROI Feb 27- March 2 Boston CROI 2011 - 17th Conference on Retroviruses and Opportunistic Infections. virus. About the Conference ... Visit Past Conferences - Home. CROI. All Rights Reserved. retroconference.org/   IAS 2011 - Rome - International AIDS Society Home Flights to Rome - Visa Information ... representative) for the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) is now open. ... www.ias2011.org   International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV 13th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV 14 - 16 July 2011, Rome, Italy http://www.intmedpress.com/lipodystrophy/   International Liver Congress, EASL 2011, Berlin The 46th Annual Meeting of the European Association for the Study of the Liver will take place in Berlin, Germany, March 30 - April 3, 2011. Abstract Information - Registration - EASL Abstracts Embargo Policy www2.kenes.com/liver-congress/Pages/Home.aspx   9th European Wshp. on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance 23-25 March 2011 - Paphos, Cyprus Venue: Coral Beach Hotel and Resort, Paphos, Cyprus - Registration and abstract submission open on 1 December - Deadline abstract submission: 28 January To be informed of all the latest developments, please sign up for our Newsletter. More Information   12th International Workshop on Clinical Pharmacology of HIV Therapy 13-15 April 2011 - Miami FL, USA Venue: Hyatt Coral Gables, Miami FL, USA - Online registration and abstract submission now possible - Deadline abstract submission: 28 January To be informed of all the latest developments, please sign up for our Newsletter. More Information   DDW | Program | Upcoming Events DDW 2011. May 7 - May 10, 2011. Exhibit Dates: May 8 - May 10 McCormick Place Chicago, IL. Schedule change for DDW 2011. As is the practice with many other ... www.ddw.org/wmspage.cfm?parm1=605   1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) 19-22 May, 2011 Barcelona, Spain http://comtecmed.com/chep/2011 chep@Comtecmed.com   7th International Workshop on HIV and Hepatits Co-Infection 1-3 June 2011 - Milan, Italy Venue is currently under deliberation - Registration and abstract submission open on 1 February 2011 - Deadline abstract submission: 1 April 2011 To be informed of all the latest developments, please sign up for our Newsletter.More Information   http://www.informedhorizons.com/resistance2011/   Chronic Viral Hepatitis - Strategies to Improve Effectiveness of Screening and Treatment June 4-5, 2011 AASLD/CDC Hepatitis Single Topic Conference Emory Conference Center, Atlanta, GA June 4 - 5, 2011: Chronic Viral Hepatitis Strategies to Improve Effectiveness of Screening and Treatment   6th International Workshop on Clinical Pharmacology of Hepatitis Therapy 22-23 June 2011 - Boston MA, USA To be informed of all the latest developments, please sign up for our Newsletter.More Information   6th International Workshop on Hepatitis C - Resistance and New Compounds 23-24 June 2011, Boston MA, USA To be informed of all the latest developments, please sign up for our Newsletter.More Information   13th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV 14 - 16 July 2011, Rome, Italy http://www.intmedpress.com/lipodystrophy/   ICAAC - Interscience Conference On Antimicrobial Agents & Chemotherapy (ICAAC) 51st ICAAC September 17 -20, 2011 Chicago, IL Interscience Conference on Antimicrobial Agents and Chemotherapy ... 2010 Interscience Conference on Antimicrobial Agents and Chemotherapy ... Save the Date. 51st ICAAC September 17 -20, 2011. Chicago, IL ... www.icaac.org/   European AIDS Clinical Society (EACS) - EACS 2011 OCTOBER 12-15 The European AIDS Clinical Society (EACS) is a not-for-profit scientific ... www.eacs-conference2011.com/eacs2011/.../European_AIDS_Clinical_Society_EACS.php   Infectious Diseases Society of America (IDSA) Join us for the 49th Annual Meeting of the Infectious Diseases Society of America in Boston, Massachusetts on October 20-23, 2011. 2011 Annual Meeting Home www.idsociety.org/Content.aspx?id=17142   2nd International Workshop on HIV & Aging 27 - 28 October 2011, Baltimore, MD, USA Venue: Renaissance Baltimore Harborplace Hotel To be informed of all the latest developments, please sign up for our Newsletter.More information   Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) AASLD The Liver Meeting® 2011 San Francisco, CA November 4 -8, 2011   HEP DART 2011 Frontiers in Drug Development for Viral Hepatitis December 4 - 8, 2011 Kauai, Hawaii, USA   http://www.hiv-workshop.com/ HIV Persistence During Therapy 5th International Workshop December 6 - 11, 2011 St. Martin, West Indies http://www.informedhorizons.com/persistence2011/       2nd International Workshop on HIV & Women January 9-10, 2012 Bethesda, Maryland   HepDART 2011 Kauai, HI USA December 4, 2011 - December 8, 2011   62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9   Second International Workshop on HIV and Aging Baltimore, MD October 27-28, 2011   EACS - 14th European AIDS Conference European AIDS Conference Oct 12-15 2011 Belgrade, Serbiay   51th ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago, IL September 17-20, 2011   6th IAS Conference on HIV Pathogenesis Treatment and Prevention July 17-20, 2011, Rome   13th Intl Workshop on Adverse Reactions & Comorbidities in HIV July 2011-Rome, Italy   The 6th International Workshop on Clinical Pharmacology of Hepatitis Therapy Boston, MA June 22-23, 2011   International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies June 7- 11, Cabo, Mexico   12th International Workshop on Clinical Pharmacology of HIV Therapy, April 13-15, 2011, Miami, FL   Eurpopean Association for the Study of the Liver March 30th - April 3rd 2011 Berlin, Germany   18th CROI Conference on Retroviruses and Opportunistic Infections February 27 - March 2, 2011 Boston, MA   The 21st Conference of the Asian Pacific Association for the Study of the Liver APASL Feb 17-20, 2011 Bangkok, Thailand   1st International Workshop on HIV and Women, January 10-11, 2011 Washington, DC   12th Intl Workshop on Adverse Reactions & Comorbidities in HIV November 5, 2010 London UK   10th International Congress on Drug Therapy in HIV Infection Glasgow November 7-11, 2010   61th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA, Hynes Convention Center October 30-November 3, 2010   First International Workshop on HIV and Aging October 4-5, 2010 Baltimore, MD   (ICAAC) 50th Interscience Conference on Antimicrobial Agents and Chemotherapy September 12-15 2010 Boston, MA   AIDS 2010 18th International AIDS Conference (IAC) July 18-23 2010 Vienna, Austria   5th International Workshop on Hepatitis C Resistance and New Compounds Boston, MA June 24-25, 2010   The 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy Boston, MA June 23-24, 2010   International HIV and Hepatitis Drug Resistance Workshop June 8-12, 2010 Dubrovnik Croatia   Microbicides Conference May 22-25, 2010 Pittsburgh, Pennsylvania   EASL 45th Annual Meeting (European Association for the Study of the Liver) April 14-18, 2010 Vienna, Austria   11th International Workshop on Clinical Pharmacology and HIV Therapy April 7-9, 2010 Sorrento, Italy   Conference of the Asian Pacific Association for the Study of the Liver 2010 20th APASL March 2010 Beijing, China   17th CROI Conference on Retroviruses and Opportunistic Infections San Francisco, CA Feb 16-19, 2010   View More Conference Reports...   Coming of AGE. A guide to ageing well with HIV - 06/15/11 La informacion Que Necesitas Sobre el VIH - 06/15/10 New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience - 06/05/07 Do you have HIV/HCV Coinfection? - 11/28/06 HIV 101 : The Basics - 11/28/06 VIH 101 : Lo Basico - in Spanish - 11/28/06 HIV 102 : Care and Treatment of HIV - 11/28/06 VIH 102 : Cuidado Y Tratamiento del VIH - in Spanish - 11/28/06 Hepatitis C and Hepatitis C Co-Infection Handbook PDF Version V 11/08/05 Download More NATAP Publications... Support provided by: Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Roche, Schering-Plough, Tibotec, Vertex   Patient Assistance Programs for HCV Therapy from the Drug Manufacturers: Pegylated Interferon and ribavirin If you cannot get reimbursement or coverage for pegylated interferon and ribavirin the manufacturers of pegylated interferon have reimbursement programs which supply free drugs if you qualify. These programs will first help you try to identify sources for reimbursement.   Schering makes Peg-Intron and ribavirin (Rebetol): Call 1-800-521-7157. Roche makes Pegasys and ribavirin (Copegus): 1-800-387-1258.   New Pegasys Patient Assistance Program   has generous provisions for patients who want to start HCV therapy with Pegasys and are uninsured. Since Roche & Genentech merged the Genentech Access Solutions P rogram took over this program starting Sept 1 2010 and as I say it is a generous transparent program.   http://www.pegasysaccesssolutions.com   866 422-2377